Unknown

Dataset Information

0

The K9 lymphoma assay allows a genetic subgrouping of canine lymphomas with improved risk classification.


ABSTRACT: We present here the K9 lymphoma assay, a novel 31-gene targeted next-generation sequencing panel designed for genomic profiling of canine lymphoid neoplasms. Addressing the growing demand for advanced diagnostics in veterinary oncology, this assay enables sensitive identification of known and actionable mutations specific to canine lymphomas, while evaluating its prognostic potential to facilitate diagnosis and prognosis. Our analysis, spanning several B- and T-cell lymphoma histotypes, unveiled distinct mutational landscapes distinguishing tumors derived from immature versus mature lymphocytes. Clustering analysis revealed a shared genetic origin between diffuse large B-cell lymphoma and marginal zone lymphoma, aligning with findings in human lymphomas, with TRAF3 emerging as the most frequently mutated gene across B-cell lymphoma subtypes. Significantly, TP53 mutations demonstrated universal adverse prognostic implications across B-cell lymphomas. Additionally, SETD2 mutations contributed to shorter time-to-progression, underscoring the role of epigenetic dysregulation in B-cell tumors. In T-cell lymphomas, SATB1 and FBXW7 were frequently mutated, warranting further investigation in larger cohorts. Our findings advocate for tailored therapeutic approaches based on the genetic profile, impacting treatment decisions and outcomes in canine lymphoma management. This study provides pivotal insights bridging veterinary and human oncology, paving the way for comprehensive genomic diagnostics and therapeutic strategies in comparative oncology.

SUBMITTER: Fanelli A 

PROVIDER: S-EPMC11319785 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

The K9 lymphoma assay allows a genetic subgrouping of canine lymphomas with improved risk classification.

Fanelli Antonella A   Licenziato Luca L   Mazzone Eugenio E   Divari Sara S   Rinaldi Andrea A   Marino Michele M   Maga Ilaria I   Bertoni Francesco F   Marconato Laura L   Aresu Luca L  

Scientific reports 20240812 1


We present here the K9 lymphoma assay, a novel 31-gene targeted next-generation sequencing panel designed for genomic profiling of canine lymphoid neoplasms. Addressing the growing demand for advanced diagnostics in veterinary oncology, this assay enables sensitive identification of known and actionable mutations specific to canine lymphomas, while evaluating its prognostic potential to facilitate diagnosis and prognosis. Our analysis, spanning several B- and T-cell lymphoma histotypes, unveiled  ...[more]

Similar Datasets

| S-EPMC9198934 | biostudies-literature
| S-EPMC9440314 | biostudies-literature
2015-04-24 | PXD002098 | Pride
| S-EPMC6872993 | biostudies-literature
| S-EPMC10811236 | biostudies-literature
2010-03-01 | GSE17189 | GEO
| S-EPMC8388421 | biostudies-literature
| S-EPMC7661784 | biostudies-literature
2012-12-10 | GSE39365 | GEO
2010-03-07 | E-GEOD-17189 | biostudies-arrayexpress